Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Loan balance May 2021
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by UglyKidStockon May 17, 2021 12:58pm
174 Views
Post# 33214637

RE:RE:Loan balance May 2021

RE:RE:Loan balance May 2021 Market cap doesn't look at your balance sheet . It is strictly based on the emotions of  stock traders.  Share price times number of shares.     EV is how much you could theoretically buy the company for today.   As debt goes down the value of the company goes up which should be reflected in a rising share price.    Anyways MRV is no flashy stock.  Steady as she goes for 12 quarters of debt reduction and  revenue increases and it's a $4 stock.    What is Bloom Burton's projection?  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities